Search

Search Constraints

You searched for: Author/Creator Li, Bob T.

Search Results

2. Lessons learned from routine, targeted assessment of liquid biopsies for EGFR T790M resistance mutation in patients with EGFR mutant lung cancers. (2nd November 2019)

3. Frequency and outcomes of brain metastases in patients with HER2‐mutant lung cancers. Issue 24 (30th August 2019)

4. Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions. (September 2021)

5. Corrigendum to "Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions" [Lung Cancer 159 (2021) 66–73]. (December 2021)

6. Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib. (April 2022)

7. Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management. (May 2022)

8. Afatinib in patients with metastatic or recurrent HER2-mutant lung cancers: a retrospective international multicentre study. (March 2019)

10. Clinical implications of drug‐induced liver injury in early‐phase oncology clinical trials. Issue 22 (18th August 2020)